DK166754B1 - Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid - Google Patents

Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid Download PDF

Info

Publication number: DK166754B1
Authority: DK; Denmark
Prior art keywords: dihydroxy; dihydrochloride; bis; hydroxyethylamino; ethylaminoaa
Prior art date: 1986-03-07

Application number

DK116687A

Other languages

Danish (da)

English (en)

Other versions

DK116687D0 (da

DK116687A (da

Inventor

Pradeep V Niphadkar

Narendra R Desai

Paul N Jones

Kieran G Mooney

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-07

Filing date

1987-03-06

Publication date

1993-07-12

1987-03-06 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1987-03-06 Publication of DK116687D0 publication Critical patent/DK116687D0/da

1987-09-08 Publication of DK116687A publication Critical patent/DK116687A/da

1993-07-12 Application granted granted Critical

1993-07-12 Publication of DK166754B1 publication Critical patent/DK166754B1/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dispersion Chemistry (AREA)
Inorganic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)

DK116687A 1986-03-07 1987-03-06 Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid DK166754B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US83724386A	1986-03-07	1986-03-07
US83724386		1986-03-07

Publications (3)

Publication Number	Publication Date
DK116687D0 DK116687D0 (da)	1987-03-06
DK116687A DK116687A (da)	1987-09-08
DK166754B1 true DK166754B1 (da)	1993-07-12

Family

ID=25273922

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK116687A DK166754B1 (da)	1986-03-07	1987-03-06	Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid

Country Status (21)

Country	Link
EP (1)	EP0236822B1 (no)
JP (1)	JPH0717500B2 (no)
KR (1)	KR900002030B1 (no)
AT (1)	ATE59290T1 (no)
AU (1)	AU593330B2 (no)
CA (1)	CA1283607C (no)
DE (1)	DE3766984D1 (no)
DK (1)	DK166754B1 (no)
ES (1)	ES2033247T3 (no)
FI (1)	FI84977C (no)
GR (1)	GR3001503T3 (no)
HK (1)	HK63991A (no)
HU (1)	HU199286B (no)
IE (1)	IE60025B1 (no)
IL (1)	IL81681A (no)
NO (1)	NO173635C (no)
NZ (1)	NZ219454A (no)
PH (1)	PH22808A (no)
PT (1)	PT84398B (no)
SG (1)	SG45292G (no)
ZA (1)	ZA871652B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE59409088D1 (de) *	1994-10-04	2000-02-24	Lohmann Rudolf Lomapharm	Lösungen von Anthrachinonen zur parenteralen Applikation
DE19818802A1 (de) *	1998-04-27	1999-10-28	Dresden Arzneimittel	Stabile Mitoxantron-Lösungen
TW200526268A (en) *	2003-12-17	2005-08-16	Takeda Pharmaceutical	Injectable composition
KR20130132496A (ko)	2010-12-09	2013-12-04	마루이시세이야쿠가부시키가이샤	아세트아미노펜의 안정화제
CN114601791B (zh) *	2020-12-08	2023-09-19	成都倍特药业股份有限公司	一种盐酸米托蒽醌液体制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3230143A (en) *	1965-05-14	1966-01-18	Merck & Co Inc	Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
US4223022A (en) *	1978-01-16	1980-09-16	Schering Corporation	Stabilized aminoglycoside antibiotic formulations
US4328213A (en) *	1979-11-28	1982-05-04	Schering Corporation	Stable injectable labetalol formulation
ATE48942T1 (de) *	1984-02-27	1990-01-15	American Cyanamid Co	Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva.

1987
- 1987-02-20 DE DE8787102448T patent/DE3766984D1/de not_active Expired - Lifetime
- 1987-02-20 ES ES198787102448T patent/ES2033247T3/es not_active Expired - Lifetime
- 1987-02-20 AT AT87102448T patent/ATE59290T1/de not_active IP Right Cessation
- 1987-02-20 EP EP87102448A patent/EP0236822B1/en not_active Expired - Lifetime
- 1987-02-26 IL IL81681A patent/IL81681A/xx not_active IP Right Cessation
- 1987-03-02 NZ NZ219454A patent/NZ219454A/en unknown
- 1987-03-04 PT PT84398A patent/PT84398B/pt unknown
- 1987-03-04 PH PH34969A patent/PH22808A/en unknown
- 1987-03-05 CA CA000531200A patent/CA1283607C/en not_active Expired - Lifetime
- 1987-03-06 IE IE56987A patent/IE60025B1/en not_active IP Right Cessation
- 1987-03-06 KR KR1019870002031A patent/KR900002030B1/ko not_active IP Right Cessation
- 1987-03-06 JP JP62050398A patent/JPH0717500B2/ja not_active Expired - Lifetime
- 1987-03-06 ZA ZA871652A patent/ZA871652B/xx unknown
- 1987-03-06 FI FI870994A patent/FI84977C/fi not_active IP Right Cessation
- 1987-03-06 HU HU87969A patent/HU199286B/hu not_active IP Right Cessation
- 1987-03-06 NO NO870950A patent/NO173635C/no unknown
- 1987-03-06 DK DK116687A patent/DK166754B1/da not_active IP Right Cessation
- 1987-03-06 AU AU69773/87A patent/AU593330B2/en not_active Expired
1991
- 1991-02-26 GR GR90400362T patent/GR3001503T3/el not_active IP Right Cessation
- 1991-08-15 HK HK639/91A patent/HK63991A/xx not_active IP Right Cessation
1992
- 1992-04-24 SG SG45292A patent/SG45292G/en unknown

Also Published As

Publication number	Publication date
HK63991A (en)	1991-08-23
FI870994A0 (fi)	1987-03-06
JPS62265220A (ja)	1987-11-18
ATE59290T1 (de)	1991-01-15
FI84977B (fi)	1991-11-15
NO870950L (no)	1987-09-08
AU6977387A (en)	1987-09-10
FI84977C (fi)	1992-02-25
KR870008581A (ko)	1987-10-19
NO173635B (no)	1993-10-04
DK116687D0 (da)	1987-03-06
SG45292G (en)	1992-06-12
FI870994A (fi)	1987-09-08
CA1283607C (en)	1991-04-30
DK116687A (da)	1987-09-08
ES2033247T3 (es)	1993-03-16
HUT47020A (en)	1989-01-30
JPH0717500B2 (ja)	1995-03-01
IE60025B1 (en)	1994-05-18
IL81681A (en)	1991-01-31
GR3001503T3 (en)	1992-11-23
DE3766984D1 (de)	1991-02-07
NZ219454A (en)	1989-04-26
PH22808A (en)	1988-12-27
PT84398A (en)	1987-04-01
EP0236822A2 (en)	1987-09-16
KR900002030B1 (ko)	1990-03-31
NO870950D0 (no)	1987-03-06
EP0236822B1 (en)	1990-12-27
AU593330B2 (en)	1990-02-08
PT84398B (pt)	1989-10-04
NO173635C (no)	1994-01-12
HU199286B (en)	1990-02-28
IE870569L (en)	1987-09-07
IL81681A0 (en)	1987-09-16
EP0236822A3 (en)	1989-01-11
ZA871652B (en)	1987-08-28

Similar Documents

Publication	Publication Date	Title
US4871742A (en)	1989-10-03	Process and pharmaceutical compositions for the treatment of glaucoma
JPS63104931A (ja)	1988-05-10	酸化に対して安定化された薬剤組成物
AU627041B2 (en)	1992-08-13	Improved nutritional formulation for the treatment of renal disease
DK161668B (da)	1991-08-05	Anvendelse af phenyleddikesyrederivater til fremstillingen af et farmaceutisk middel til behandling af eller forebyggelse mod oejenbetaendelse
IE58450B1 (en)	1993-09-22	Basic formulations of quinolonecarboxylic acids
DK166754B1 (da)	1993-07-12	Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid
MXPA02000849A (es)	2002-07-30	Composicion oftalmica que comprende cetotifeno.
EP0467856A3 (en)	1992-10-14	Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases
US3966905A (en)	1976-06-29	Stabilized catechol amine solutions
US5354771A (en)	1994-10-11	Methods for treatment of sepsis using branch chain amino acids
EP0345926B1 (en)	1991-08-07	Pharmaceutical compositions containing pentamidine
CA2477773C (en)	2011-01-18	A stable diclofenac-tromethamine composition for the topical treatment of oropharyngeal cavity disorders
US6114387A (en)	2000-09-05	Pharmaceutical composition for oral administration of chelating agents
BR9910628A (pt)	2001-01-30	Uso de um composto da série da benzofuroxana, composição farmacêutica, e, processos para a preparação de uma formulação parenteral e para o tratamento de um mamìfero, incluindo um ser humano, de doenças cardìacas da coronária
KR19980070878A (ko)	1998-10-26	새로운 진통제 조성물
AU3522599A (en)	1999-11-16	Stable mitoxantron solutions
Stine et al.	1984	N-(2, 3-dimercaptopropyl) phthalamidic acid: protection, in vivo and in vitro, against arsenic intoxication
Lemaire et al.	1994	The tris formulation of Fluorouracil is more cardiotoxic than the sodium-salt formulations
BR0002265A (pt)	2001-03-13	Inibidores da metaloprotease, um processo para seu preparo e composições farmacêuticas contendo os mesmos
US6034126A (en)	2000-03-07	Method for treating glycol poisoning
US4271191A (en)	1981-06-02	Method of treating hyperuricemia and gout
BR9707303A (pt)	2000-05-02	Agentes terapêuticos para asma
HUT64354A (en)	1993-12-28	Process for preparing vanady-complexes of hydroxamate chelate producing agents and pharmaceutical preparatives containing said compounds
KR910004192A (ko)	1991-03-28	프로페니토인의 치료적 유효량을 함유하는 발작증 치료용 제약 조성물
CH666183A5 (it)	1988-07-15	Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.

Legal Events

Date	Code	Title	Description
1993-07-12	B1	Patent granted (law 1993)
2007-03-26	PUP	Patent expired